A previous study conducted at the same institution, with a patient population of 77, concluded that high dose dexmedetomidine can be successfully used for MRI sedation in children, with 29% of patients requiring additional agents for optimal sedation . In our study, over the course of five years, the patient cohort was larger (544 patients) and included the previously reported 77-patient cohort. This larger patient cohort analysis validated previously reported data: 100% success of the existing sedation protocol, rounded up from 99.8% acknowledging one patient failure, with the adjunctive sedative agents used on 21.5% of cases.
Corrigendum | Open Access
Corrigendum to “High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI”
Received17 May 2015
Accepted25 May 2015
Published02 Jun 2015
Copyright
Copyright © 2015 Sheikh Sohail Ahmed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.